Reduced platelet transfusions and earlier platelet engraftment using alemtuzumab-based conditioning regimen in allogeneic stem cell transplantation

PURPOSE: In patients undergoing allogeneic stem cell transplantation, conditioning regimens containing alemtuzumab instead of anti-thymocyte globulin (ATG) may result in an earlier platelet engraftment and a reduced number of platelet transfusions

Bibliographic Details
Published in:Journal of cancer research and clinical oncology, Vol. 142, No. 5 (2016), p. 1091-7
Main Author: Neumann, Thomas (Author)
Other Involved Persons: Schneidewind, Laila ; Thiele, Thomas ; Schulze, Meike ; Klenner, Anne F ; Busemann, Christoph ; Pink, Daniel ; Greinacher, Andreas ; Dölken, Gottfried ; Krüger, William H
Format: electronic Article
Language:English
ISSN:1432-1335
Item Description:Date Completed 30.08.2016
Date Revised 13.11.2018
published: Print-Electronic
Citation Status MEDLINE
Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Physical Description:Online-Ressource
DOI:10.1007/s00432-016-2114-7
Subjects:
ATG
QR Code: Show QR Code